FMR LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$644,735
-15.0%
118,300
+4.7%
0.00%
Q2 2023$758,357
-52.9%
113,019
-38.0%
0.00%
Q1 2023$1,610,310
+131.3%
182,368
+100.1%
0.00%
Q4 2022$696,188
+12.3%
91,124
+4.6%
0.00%
Q3 2022$620,000
+513.9%
87,112
+597.4%
0.00%
Q2 2022$101,000
+17.4%
12,491
+101.8%
0.00%
Q1 2022$86,000
-99.7%
6,190
-99.5%
0.00%
-100.0%
Q4 2021$32,113,000
+72884.1%
1,144,452
+89101.2%
0.00%
Q3 2021$44,000
-96.1%
1,283
-95.3%
0.00%
Q2 2021$1,123,000
-91.9%
27,467
-92.0%
0.00%
-100.0%
Q1 2021$13,895,000
-88.3%
345,123
-82.8%
0.00%
-90.9%
Q4 2020$118,335,000
+148.7%
2,001,250
+104.5%
0.01%
+120.0%
Q3 2020$47,580,000
+162.2%
978,412
+160.8%
0.01%
+150.0%
Q2 2020$18,148,000
+41.3%
375,101
-18.8%
0.00%0.0%
Q1 2020$12,840,000
-17.0%
462,181
-10.6%
0.00%0.0%
Q4 2019$15,475,000
+2.9%
517,229
+6.3%
0.00%0.0%
Q3 2019$15,042,000
-48.6%
486,803
-19.7%
0.00%
-33.3%
Q2 2019$29,289,000606,4000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders